Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 12/04/20161 min de lecture
Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is proposing to withdraw approval of all new animal drug applications (NADAs) providing for use of carbadox in medicated swine feed. This action is based on CVM's determination that the use of carbadox under the approved conditions of use results in residues of carcinogenic concern in the edible tissues of the treated swine.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →